Acting as a cluster, miR-411 and miR-379 inhibited the invasion of malignant pleural mesothelioma cells and appeared to decrease drug resistance (vorinostat (SAHA) and pemetrexed (PEM)) by directly targeting interleukin (IL)-18 [38]. This evidence concerns the gene IL18 and pleural mesothelioma.